Programming peripheral artery disease in diabetes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 42018667.
- Also identified by DOI 10.1126/scitranslmed.aef8756.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Reprogrammed TREM2<sup>+</sup> macrophages drive nonresolving inflammation in peripheral artery disease associated with type 2 diabetes (Malhi <i>et al.</i>, this issue).
Medical subject headings
- Peripheral Arterial Disease
- Diabetes Mellitus, Type 2